Novartis Sells U.S. Rights to Enablex for $400 Million
Ireland-based Warner Chilcott will take over the marketing, sales and manufacturing of the drug in the United States, Novartis said in a statement. The deal is expected to close by the end of October.
In 2005, Novartis agreed to work with Procter & Gamble Pharmaceuticals to promote and develop the drug in the United States. Warner Chilcott purchased Procter & Gamble Pharmaceuticals in October 2009.